Yayın:
Serum apolipoprotein B predicts hypertension, dyslipidemia, metabolic syndrome and, in women, diabetes

Basit öğe sayfası
dc.contributor.authorHergenc, G.
dc.contributor.authorOnat, A.
dc.contributor.authorCan, G.
dc.contributor.authorYazici, M.
dc.contributor.authorKarabulut, A.
dc.contributor.authorAlbayrak, S.
dc.date.accessioned2026-06-27T13:05:46Z
dc.date.issued2007
dc.identifier.endpageA41
dc.identifier.issn0009-9147
dc.identifier.issue6
dc.identifier.startpageA41
dc.identifier.urihttps://hdl.handle.net/20.500.14981/49656
dc.identifier.volume53
dc.identifier.wos000246843000130
dc.language.isoeng
dc.publisherAMER ASSOC CLINICAL CHEMISTRY
dc.relation.conference59th Annual Meeting of the American-Association-for-Clinical-Chemistry
dc.relation.ispartofCLINICAL CHEMISTRY
dc.subjectMedical Laboratory Technology
dc.titleSerum apolipoprotein B predicts hypertension, dyslipidemia, metabolic syndrome and, in women, diabetes
dc.typeMeeting Abstract
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar

Yayınlar